Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net loss	$ (4,791,155)	$ (1,846,437)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	31,851	24,993
Amortization of patents	26,506	26,506
Inventory reserve		(2,061)
Stock compensation	58,219	101,700
Employees paid in stock	714,005
Expense paid in stock	406,800
Non-cash operating lease expense	28,901
Earnings on China joint venture		(49,100)
Change in fair value of derivative liability		(52,722)
Changes in operating assets and liabilities:
Decrease in accounts receivable	1,603,379	319,537
Decrease in accounts receivable, related party		100,000
Decrease in other assets	11,755	9,523
(Increase) decrease in inventories	(231,944)	652,631
(Increase) decrease in advances on contracts	(131,518)	118,669
Decrease in prepaid expenses and other current assets	50,162	7,978
(Decrease) in accounts payable	(917,898)	(12,573)
(Decrease) in accounts payable, related party	(839,359)	(380,482)
Decrease in deferred cost, related party		50,000
Increase in accrued expenses	272,953	284,128
(Decrease) increase in accrued expenses, related party	(404,161)	125,428
(Decrease) in deferred revenue, related party		(99,997)
Net cash used in operating activities	(4,111,504)	(622,279)
Cash flows from investing activities:
Purchase of property and equipment	(15,499)	(8,104)
Net cash used in investing activities	(15,499)	(8,104)
Cash flows from financing activities:
Proceeds from exercise of warrants	949,012
Payments finance lease obligations	(4,937)
Net proceeds from note payable	272,099
Net proceeds from Public Placement Offering	18,003,037	1,974,547
Net proceeds from Private Placement Offering		250,000
Net cash provided by financing activities	19,220,948	2,224,547
Net increase (decrease) in cash and cash equivalents	15,093,945	1,594,164
Cash and cash equivalents at beginning of period	1,516,272	743,429
Cash and cash equivalents at end of period	16,610,217	2,337,593
Supplemental non-cash disclosure of cash flow information:
Shares issued to board of directors		37,000
Shares issued to employees for compensation		22,500
Shares issued to consultants in lieu of cash payments		180,000
Initial recognition of operating lease-right of use assets	706,251	(166,292)
Initial recognition of operating lease right to used liabilities	(706,251)	166,292
Derivative liability		$ 1,471,585